287
Views
18
CrossRef citations to date
0
Altmetric
Original

Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis

, , , , &
Pages 445-454 | Received 08 Sep 2011, Accepted 19 Dec 2011, Published online: 31 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shaheen Sultana, Nada Alzahrani, Reem Alzahrani, Wejdan Alshamrani, Waad Aloufi, Amena Ali, Shehla Najib & Nasir Ali Siddiqui. (2020) Stability issues and approaches to stabilised nanoparticles based drug delivery system. Journal of Drug Targeting 28:5, pages 468-486.
Read now
Jafar Ezzati Nazhad Dolatabadi, Hamed Hamishehkar & Hadi Valizadeh. (2015) Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Drug Development and Industrial Pharmacy 41:9, pages 1431-1437.
Read now
Shaheen Sultana, Aseem Bhatnagar, Harish Rawat, Dhruv Kumar Nishad, Sushma Talegaonkar, Farhan Jalees Ahmad & Gaurav Mittal. (2014) Pulmonary delivery of nanosized alendronate for decorporation of inhaled heavy metals: formulation development, characterization and gamma scintigraphic evaluation. Pharmaceutical Development and Technology 19:5, pages 623-633.
Read now

Articles from other publishers (15)

Ho Wan Chan, Stephanie Chow, Xinyue Zhang, Yayi Zhao, Henry Hoi Yee Tong & Shing Fung Chow. (2023) Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research. AAPS PharmSciTech 24:4.
Crossref
Alaa Ibrahim, Omar A. Abdel Aziz, Ahmed S. Abo Dena & Ibrahim M. El-Sherbiny. 2023. Advanced and Modern Approaches for Drug Delivery. Advanced and Modern Approaches for Drug Delivery 91 111 .
Si Nga Wong, Jingwen Weng, Ignatius Ip, Ruipeng Chen, Richard Lakerveld, Richard Telford, Nicholas Blagden, Ian J. Scowen & Shing Fung Chow. (2022) Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline. Pharmaceutics 14:2, pages 300.
Crossref
Bruno Iles, Isabela Ribeiro de Sá Guimarães Nolêto, Flaviane França Dourado, Fábio de Oliveira Silva Ribeiro, Alyne Rodrigues de Araújo, Taiane Maria de Oliveira, Jessica Maria Teles Souza, Ayslan Batista Barros, Gabrielle Costa Sousa, Antônia Carla de Jesus Oliveira, Conceição da Silva Martins, Mariana de Oliveira Viana Veras, Renata Ferreira de Carvalho Leitão, José Roberto de Souza de Almeida Leite, Durcilene Alves da Silva & Jand Venes Rolim Medeiros. (2021) Alendronate sodium-polymeric nanoparticles display low toxicity in gastric mucosal of rats and Ofcol II cells. NanoImpact 24, pages 100355.
Crossref
Biswadip Sinha, Sven Staufenbiel, Rainer H. Müller & Jan P. Möschwitzer. (2021) Sub-50 nm ultra-small organic drug nanosuspension prepared by cavi-precipitation and its brain targeting potential. International Journal of Pharmaceutics 607, pages 120983.
Crossref
Al Sayed A. N. Sallam. 2021. Design of Experiments for Pharmaceutical Product Development. Design of Experiments for Pharmaceutical Product Development 97 115 .
Tanmoy Das, M.P. Venkatesh, T.M. Pramod Kumar & Marina Koland. (2020) SLN based alendronate in situ gel as an implantable drug delivery system – A full factorial design approach. Journal of Drug Delivery Science and Technology 55, pages 101415.
Crossref
Geetanjali B. Tomar, Jay R. Dave, Suhas T. Mhaske, Sachin Mamidwar & Prajakta K. Makar. 2020. Functional Bionanomaterials. Functional Bionanomaterials 209 250 .
Al Sayyed A.N. Sallam. 2019. Pharmaceutical Quality by Design. Pharmaceutical Quality by Design 173 192 .
Gabriela Daisy Hadiwinoto, Philip Chi Lip Kwok & Richard Lakerveld. (2018) A review on recent technologies for the manufacture of pulmonary drugs. Therapeutic Delivery 9:1, pages 47-70.
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de VoordeSalma Nabil Tammam & Alf Lamprecht. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production 101 134 .
Al Sayyed Sallam, Sami Nazzal, Hatim S. AlKhatib & Nabil Darwazeh. 2015. Pulmonary Drug Delivery. Pulmonary Drug Delivery 321 338 .
Varaporn Buraphacheep Junyaprasert & Boontida Morakul. (2015) Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian Journal of Pharmaceutical Sciences 10:1, pages 13-23.
Crossref
Biswadip Sinha, Rainer H. Müller & Jan P. Möschwitzer. (2013) Bottom-up approaches for preparing drug nanocrystals: Formulations and factors affecting particle size. International Journal of Pharmaceutics 453:1, pages 126-141.
Crossref
K. Miladi, S. Sfar, H. Fessi & A. Elaissari. (2013) Drug carriers in osteoporosis: Preparation, drug encapsulation and applications. International Journal of Pharmaceutics 445:1-2, pages 181-195.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.